nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer
Titel:
nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2– metastatic breast cancer
Auteur:
Hamilton, Erika Cortes, Javier Ozyilkan, Ozgur Chen, Shin-Cheh Petrakova, Katarina Manikhas, Aleksey Jerusalem, Guy Hegg, Roberto Huober, Jens Zhang, Wei Chen, Yanyun Martin, Miguel